Pathophysiology of Type 2 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 293 of the 297 references it cites were found in a registry or an index.
Abstract
Type 2 Diabetes Mellitus (T2DM), one of the most common metabolic disorders, is caused by a combination of two primary factors: defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to respond appropriately to insulin. Because insulin release and activity are essential processes for glucose homeostasis, the molecular mechanisms involved in the synthesis and release of insulin, as well as in its detection are tightly regulated. Defects in any of the mechanisms involved in these processes can lead to a metabolic imbalance responsible for the development of the disease. This review analyzes the key aspects of T2DM, as well as the molecular mechanisms and pathways implicated in insulin metabolism leading to T2DM and insulin resistance. For that purpose, we summarize the data gathered up until now, focusing especially on insulin synthesis, insulin release, insulin sensing and on the downstream effects on individual insulin-sensitive organs. The review also covers the pathological conditions perpetuating T2DM such as nutritional factors, physical activity, gut dysbiosis and metabolic memory. Additionally, because T2DM is associated with accelerated atherosclerosis development, we review here some of the molecular mechanisms that link T2DM and insulin resistance (IR) as well as cardiovascular risk as one of the most important complications in T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“T2D is considered a polygenic condition with considerable heterogeneity in degrees of insulin deficiency and resistance and accounts for >90% of all cases of DM.32”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“Likewise, diabetes is secondary to altered glucose homeostasis [67], and this study suggests a critical role for NHE3 in the regulation of SGLT1, which is the predominant intestinal glucose transporter.”
From Regulation of Enterocyte Brush Border Membrane Primary Na-Absorptive Transporters in Human Intestinal Organoid-Derived Monolayers (2024) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 2×
“A critical component of T2DM is a chronic low-grade inflammatory state, referred to as “metaflammation” [250].”
Background10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“Among them, the UKPDS post-trial study and Steno-2 trial showed that specifically early glycemic interventions prevent diabetic complication and has a marked decrease in CVD endpoints in patients that received either standard or intensive treatment following their diagnosis [84].”
BackgroundHaffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · cited 1×
“In these circumstances, as a consequence of nutrient overload, electron supply to the mitochondrial ETC increases and the electron excess is transferred to oxygen generating O2− and subsequent hydrogen peroxide [127].”
BackgroundMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 1×
“A high-fat diet can induce up to threefold lipopolysaccharide (from Gram-negative bacteria) production in mice models, thereby contributing to low-grade inflammation and insulin resistance [76,77].”
BackgroundEckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Research works printed but not linked: 1
- Simmons D. Epigenetic Influences and Disease Nat. Educ. 2008 1 6
Cited by
Items 701–800 of 1,005
Mabate, B., Daub, C. D., Malgas, S., & Pletschke, B. I. (2024) · Algal Research · doi:10.1016/j.algal.2024.103885 · Cited by 15
Mitochondrial DNA variants in the pathogenesis and metabolic alterations of diabetes mellitus
S, P. K. K., Jyothi, M. N., & Prashant, A. (2024) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2024.101183 · Cited by 29
Palmas, V., Deledda, A., Heidrich, V., Sanna, G., Cambarau, G., Fosci, M., Puglia, L., Cappai, E. A., Lai, A., Loviselli, A., et al. (2025) · Metabolites · doi:10.3390/metabo15010022 · Cited by 14
“T2DM is linked to both modifiable and unmodifiable risk factors, such as genetic predisposition [8], and is closely connected to lifestyle [9].”
Tonin, G., Goričar, K., Blagus, T., Janež, A., Dolžan, V., & Klen, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1547920 · Cited by 18
“Not surprisingly, this is consistent with the well-described role of obesity in the development and progression of T2DM and is also relevant for the treatment effect (45, 46).”
Wang, J., Zhang, L., Cao, H., Shi, X., Zhang, X., Gao, Z., Ikeda, K., Yan, T., Jia, Y., & Xu, F. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154022 · Cited by 13
Nesfatin-1 – as a diagnosis regulatory peptide in type 2 diabetes mellitus
Kadim, B. M., & Hassan, E. A. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01070-8 · Cited by 12
“Moreover, insulin resistance is a metabolic defect of diabetes type 2 that has emerged as a new global reaction to the epidemic [3].”
BackgroundAdvances in FGFs for diabetes care applications
Liu, Y., Chen, Q., Li, Y., Bi, L., He, Z., Shao, C., Jin, L., Peng, R., & Zhang, X. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121015 · Cited by 12
Alshammary, A. F., Al-Hakeem, M. M., & Khan, I. A. (2023) · Genes · doi:10.3390/genes14040924 · Cited by 14
“Chronically abnormal blood sugar levels are a hallmark of this potentially lethal metabolic condition [1].”
BackgroundChen, L., Li, H., Ru, Y., Song, Y., Shen, Y., Zhao, L., Huang, G., Chen, Y., Qi, Z., Li, R., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.163592 · Cited by 14
Bucolo, G. M., D’Angelo, T., Yel, İ., Koch, V., Gruenewald, L. D., Othman, A. E., Alizadeh, L. S., Overhoff, D., Waldeck, S. S., Martin, S. S., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13101790 · Cited by 15
“Type 2 diabetes mellitus (DM) is the most common metabolic disorder in the world, with an incidence and prevalence greater than 80% in patients living in low-to-middleincome countries [1].”
BackgroundRampadarath, A., Aribisala, . O., Makunga, N. P., Mazibuko-Mbeje, S. E., & Sabiu, S. (2023) · South African Journal of Botany · doi:10.1016/j.sajb.2023.08.045 · Cited by 13
Afzal, S., al‐Rashida, M., Hameed, A., Pelletier, J., Sévigny, J., & Iqbal, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.585876 · Cited by 13
“In pancreatic β-cells, both receptor types have been reported to be involved in the regulation of insulin secretion; however, their mode of action is slightly different (Galicia-Garcia et al., 2020).”
BackgroundJones, M., Ionescu, C. M., Walker, D., Wagle, S. R., Kovačević, B., Chester, J., Foster, T., Johnston, E., Kuthubutheen, J., Brown, D. J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020836 · Cited by 15
GLP-1 and Its Role in Glycogen Production: A Narrative Review
Lotosky, J., Jean, X., Altankhuyag, A., Khan, S. R., Bernotas, A., Sharafshah, A., Blum, K., Posner, A. R., & Thanos, P. K. (2025) · Biomedicines · doi:10.3390/biomedicines13071610 · Cited by 17
Weiskirchen, R., & Lonardo, A. (2025) · Medical Sciences · doi:10.3390/medsci13040265 · Cited by 22
“These mechanisms collectively trigger and sustain inflammation, atherosclerosis, and organ-specific complications such as retinopathy, nephropathy, neuropathy, metabolic-dysfunction associated steatotic liver disease (MASLD), cardiopathy, and brain disease [5].”
Sizoo, D., Stam, S. P., de Heide, L. J. M., Emous, M., van Zutphen, T., van Dijk, P. R., & van Beek, A. P. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110197 · Cited by 13
Amalia, M., Puteri, M. U., Saputri, F. C., Sauriasari, R., & Widyantoro, B. (2023) · Life · doi:10.3390/life13071473 · Cited by 16
“Therefore, a low insulin or insulin resistance level can increase platelet reactivity [5,17].”
BackgroundKoning, E., Grigolon, R. B., Breda, V., Gomes, F. A., Zucatti, K. P., Teixeira, P. P., Colpani, V., Gerchman, F., & Brietzke, E. M. (2023) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2023.111445 · Cited by 15
Zuo, Z., Yi, T., Li, M., Wang, Z., Wang, X., Guo, X., Sun, Y., & Zhang, Z. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.08.003 · Cited by 13
Diabetes in childhood cancer survivors: emerging concepts in pathophysiology and future directions
Bhandari, R., Armenian, S. H., McCormack, S. E., Natarajan, R. D., & Mostoufi‐Moab, S. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1206071 · Cited by 14
“org impaired due to accumulated triglyceride and FFA levels in the liver, leading to increased hepatic gluconeogenesis (15).”
BackgroundFibroblast Growth Factor 21 in Gestational Diabetes Mellitus and Type 2 Diabetes Mellitus
Gawlik, K., Milewicz, T., Pawlica-Gosiewska, D., Trznadel-Morawska, I., & Solnica, B. (2023) · Journal of Diabetes Research · doi:10.1155/2023/4024877 · Cited by 12
“Chronic hyperglycaemia is associated with long-term damage and failure of multiple organs—particularly the eyes, kidneys, nerves, heart, and blood vessels [1].”
BackgroundIn Vivo Electrochemical Measurement of Glucose Variation in the Brain of Early Diabetic Mice
Zhu, B., Li, X., Zhu, L., Qi, M., Cao, J., Zhou, L., & Su, B. (2023) · ACS Sensors · doi:10.1021/acssensors.3c01165 · Cited by 11
Mkabayi, L., Viljoen, Z., Krause, R. W. M., Lobb, K. A., Pletschke, B. I., & Frost, C. L. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23289 · Cited by 13
“Uncontrolled DM can lead to a number of complications related to kidney damage, nerve damage, blindness and cardiovascular diseases [3 – 6].”
BackgroundChauhan, S., Jhawat, V., Singh, R. P., & Yadav, A. (2024) · Burns · doi:10.1016/j.burns.2024.01.008 · Cited by 13
Yang, T., Wu, C., Li, Y., Wang, C., Mao, Z., Huo, W. Q., Yan, L., Li, Y., Xing, W., & Li, L. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.03.014 · Cited by 14
Senescent adipocytes and type 2 diabetes – current knowledge and perspective concepts
Kruczkowska, W., Gałęziewska, J., Kciuk, M., Gielecińska, A., Płuciennik, E., Pasieka, Z. W., Zhao, L.-Y., Yu, Y.-J., Kołat, D., & Kałuzińska‐Kołat, Ż. (2024) · BioMolecular Concepts · doi:10.1515/bmc-2022-0046 · Cited by 16
“A ff ected individuals su ff er from insulin resistance or intolerance, meaning that there is a lack of response to this hormone from tissues or even the whole organism [12,22].”
BackgroundInfluentialErdõs, B., O’Donovan, S. D., Adriaens, M. E., Gijbels, A., Trouwborst, I., Jardon, K. M. C., Goossens, G. H., Afman, L. A., Blaak, E. E., van Riel, N. A. W., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-58703-6 · Cited by 10
Seo, J. H., & Lee, Y. (2024) · Biomedicines · doi:10.3390/biomedicines12040866 · Cited by 34
“FG levels are often used for screening and evaluating prediabetes and T2D [54,55].”
BackgroundRech, L., Zahradka, P. C., & Taylor, C. G. (2024) · Nutrients · doi:10.3390/nu16121819 · Cited by 14
“An excessive accumulation of fat in the liver, known has hepatic steatosis, is common in type 2 diabetes, and may precede or exacerbate hepatic insulin resistance [2].”
BackgroundInfluentialAlmalki, N. A. R., Al-Abbasi, F. A., Moglad, E. H. O., Afzal, M., Al-Qahtani, S. D., Alzarea, S. I., Imam, F., Sayyed, N., & Kazmi, I. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38625 · Cited by 19
Nxumalo, M. B., Ntanzi, N., Kumalo, H. M., & Khan, R. B. (2024) · Nutrients · doi:10.3390/nu16203496 · Cited by 15
“Additionally, peripheral tissues become resistant to insulin due to impaired insulin-signalling pathways, leading to high levels of glucose in the bloodstream, or hyperglycaemia [3,11].”
BackgroundInfluentialNanotechnology as a potential treatment for diabetes and its complications: A review
Manral, K., Singh, A., & Singh, Y. L. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103159 · Cited by 16
Situmorang, P. C., Zuhra, C. F., Lutfia, A., Pasaribu, K. M., Hardiyanti, R., & Nugraha, A. P. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106799 · Cited by 18
Chen, X., Zhang, J., Lü, F., Hu, R., Du, X., Xu, C., Liang, M., Chen, L., Yao, W., Ma, Z., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1582495 · Cited by 12
“Given that T2DM is a complex metabolic disorder characterized by chronic low-grade inflammation, IR, and vascular dysfunction (20), these pathophysiological characteristics may amplify the UHR-CKD association by enhancing oxidative stress and inflammatory cascades, potentially involving pathways…”
Marselou, E., Kelekis, A., Dimitriadis, Z., & Koumantakis, G. Α. (2025) · Osteoporosis International · doi:10.1007/s00198-025-07523-z · Cited by 17
“T2D is caused by impaired insulin secretion by pancreatic β-cells and reduced responsiveness of insulin-sensitive tissues to insulin [35]."”
VEGH, A., Bányai, D., Ujpál, M., Somogyi, K. S., Biczó, Z., Kammerhofer, G., Németh, Z., Hermann, P., Payer, M., & Végh, D. (2021) · Anticancer Research · doi:10.21873/anticanres.15464 · Cited by 13
Biancolin, A. D., Jeong, H., Mak, K. W. Y., Yuan, Z., & Brubaker, P. L. (2022) · Endocrinology · doi:10.1210/endocr/bqac118 · Cited by 13
Design of Improved Antidiabetic Drugs: A Journey from Single to Multitarget Agents
Tassopoulou, V., Tzara, A., & Kourounakis, A. P. (2022) · ChemMedChem · doi:10.1002/cmdc.202200320 · Cited by 17
Натрус, Л. В., Osadchuk, Y., Lisakovska, O., Roch, T., Babel, N., Klys, Y., Labudzynskyi, D. О., & Chaikovsky, Y. B. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11529 · Cited by 12
Associations between migraine and major cardiovascular events in type 2 diabetes mellitus
Cheon, D. Y., Han, K., Yang, Y., Kim, Y., Lee, S., Kim, C., Sohn, J., Oh, M. S., Lee, B., Lee, M., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01705-3 · Cited by 11
“Introduction Type 2 diabetes mellitus (T2DM) is a chronic condition that develops when the body cannot effectively produce and utilize insulin [1].”
BackgroundAkácsos-Szász, O.-Z., Pál, S., Nyulas, K.-I., Nemes-Nagy, E., Fárr, A.-M., Dénes, L., Szilveszter, M., Bán, E.-G., Tilinca, M. C., & Simon-Szabó, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054319 · Cited by 14
Nema, P., Asati, V., Kendya, P., Gupta, T., Agarwal, S., Kori, S. K., Kashaw, V., Iyer, A. K., & Kashaw, S. K. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557523666230302140658 · Cited by 12
Promsrisuk, T., Kongsui, R., Sriraksa, N., Boonla, O., & Srithawong, A. (2023) · Journal of Exercise Rehabilitation · doi:10.12965/jer.2346040.020 · Cited by 16
“The development of T2DM is pri- marily caused by a defective insulin secretion by pancreatic β-cells, or the incapacity of insulin-sensitive tissues to respond to insulin in term of is insulin resistance (Galicia-Garcia et al., 2020).”
BackgroundTransfer RNA Mutation Associated with Type 2 Diabetes Mellitus
Rahmadanthi, F. R., & Maksum, I. P. (2023) · Biology · doi:10.3390/biology12060871 · Cited by 11
Wongmanee, N., Rojanaverawong, W., Boonsong, T., & Hanchang, W. (2023) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2023.08.005 · Cited by 15
“1,3,4 Therefore, exploring the therapeutic agents for the protection of pancreatic b -cells and the improvement of their function to synthesize and release insulin is important in the prevention and control of diabetes.”
BackgroundThe Ameliorative Effects of Selenium Nanoparticles (SeNPs) on Diabetic Rat Model: A Narrative Review
Tarmizi, A. A. A., Adam, S. H., Ramli, N. N. N., Hadi, N. A. A., Mutalib, M. A., Tang, S. G. H., & Mokhtar, M. H. (2023) · Sains Malaysiana · doi:10.17576/jsm-2023-5207-12 · Cited by 12
Fatmawati, S., Auwaliyah, F., Yuliana, Y., Hasanah, N., Putri, D. A., Kainama, H., & Choudhary, M. I. (2023) · Scientific Reports · doi:10.1038/s41598-023-45357-z · Cited by 25
Cipriani, C., Lauriero, G., Tripepi, G. L., Ferrari, S., Bover, J., Ravera, M., Barbuto, S., Cianciolo, G., Nicola, L. D., Brandi, M. L., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12237260 · Cited by 13
“Insulin resistance contributes to increased glucose production in the liver and decreased glucose uptake in the muscle, liver, and adipose tissue [15].”
BackgroundInfluentialZhang, Z., Li, C., Xiao, Y., Liu, C., Luo, X.-Q., Wang, C., Dai, Y., Lin, Q., Zhang, Z., Zheng, C., et al. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2536204 · Cited by 17
“Infiltration of macrophages and T cells into adipose tissue triggers secretion of pro-inflammatory cytokines [e.g. tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6)], which are strongly associated with cardiovascular disease (CVD), diabetic complications, and premature mortality [7–9].”
Emerging Biomarkers and Nanobiosensing Strategies in Diabetes
Baranwal, A., Bansal, V., & Shukla, R. (2025) · Biosensors · doi:10.3390/bios15100639 · Cited by 14
Kyhl, L. K., Nordestgaard, B. G., Tybjærg‐Hansen, A., & Nielsen, S. F. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120551 · Cited by 16
Chen, Y., Jin, D., Han, X., Liu, X., Liu, Y., & Wang, L. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1856667 · Cited by 14
“Despite being signi fi cant upstream stressors, obesity and a surplus of nutrients do not adequately account for the chronic in fl amma-tory tone and signalling abnormalities seen in T2DM, indicating the existence of other metabolic modulators that persistently disrupt insulin function (2).”
Reynaud, O., Wang, J. P., Ayoub, M., Leduc‐Gaudet, J., Mayaki, D., Dulac, M., Hussain, S. N. A., Bergeron, R., & Gouspillou, G. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00388.2022 · Cited by 12
Srisuporn, P., Navasumrit, P., Ngaotepprutaram, T., Chaisatra, K., Hunsonti, P., & Ruchirawat, M. (2023) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2023.114124 · Cited by 12
Fajarwati, I., Solihin, D. D., Wresdiyati, T., & Batubara, I. (2023) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/1174/1/012035 · Cited by 21
“Diabetes is characterized by abnormally high levels of blood glucose [3].”
BackgroundEpigenetic changes underlie the association between diabetes mellitus and oral diseases
veysari, S. K., Asghari, M., Farshad, F., & Hodjat, M. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08574-3 · Cited by 11
Sharifi-Rigi, A., Zal, F., Aarabi, M. H., Rad, N. R., Naghibalhossaini, F., Shafiee, S. M., & Aminorroaya, A. (2023) · Gene Reports · doi:10.1016/j.genrep.2023.101844 · Cited by 13
Mashile, B., Setlhodi, R., Izu, G. O., Erukainure, O. L., Mashele, S. S., Makhafola, T. J., Eze, K. C., & Chukwuma, C. I. (2023) · International Journal of Food Science & Technology · doi:10.1111/ijfs.16823 · Cited by 10
Prevalence and risk factors of diabetes mellitus among elderly patients in the Lugu community
Zhao, L., Li, W., & Ma, Y. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i4.638 · Cited by 20
Zaki, S., Alam, F., Faizan, M., Sharma, S. R., & Naqvi, I. H. (2024) · Journal of Human Sport and Exercise · doi:10.55860/eazehg56 · Cited by 11
Ali, H. S., Al-Amodi, H. S. A. B., Hamady, S., Roushdy, M. M. S., Hasanin, A. H., Ellithy, G., Elmansy, R. A., Ahmed, H. H. T., Ahmed, E. M. E., Elzoghby, D. M. A., et al. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00023d · Cited by 10
Chang, S., & Liu, H. (2024) · Research in Sports Medicine · doi:10.1080/15438627.2024.2349521 · Cited by 11
“Its specific pathogenesis is still unclear, and the main clinical manifestation is the decreased ability to self-produce insulin to regulate glucose metabolism (Galicia-Garcia et al., 2020; Oguntibeju, 2019).”
Berraquero‐García, C., Martínez-Sánchez, L., Guadix, E. M., & García‐Moreno, P. J. (2024) · Nanomaterials · doi:10.3390/nano14100840 · Cited by 15
“T2DM is a metabolic disorder characterized by chronically high blood sugar levels due to insulin resistance and insufficient insulin secretion [2].”
BackgroundTestosterone and Glucose Homeostasis in Adult Males: Current Insights and Future Prospects
Milionis, C., Koukkou, E. G., Venaki, E., & Ilias, Ι. (2024) · Discovery Medicine · doi:10.24976/discov.med.202436184.81 · Cited by 12
Almayda, N., Masruri, M., & Safitri, A. (2024) · Scientifica · doi:10.1155/2024/9097238 · Cited by 13
Diabetes and Infectious Diseases with a Focus on Melioidosis
Kumar, A. U., Zan, M. A., Ng, C.-L., Chieng, S., & Nathan, S. (2024) · Current Microbiology · doi:10.1007/s00284-024-03748-z · Cited by 10
Li, L., Pan, L., Lin, Z., Wen, J., Tan, B., Liu, H., & Hu, Y. (2024) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2024.109976 · Cited by 15
Ajwani, J., Hwang, E., Portillo, B., Lieu, L., Wallace, B., Kabahizi, A., He, Z., Dong, Y., Grose, K. C., & Williams, K. W. (2024) · Neuropeptides · doi:10.1016/j.npep.2024.102461 · Cited by 11
Exploring the recent advancements and future prospects of personalized medicine in type 2 diabetes
Nameghi, S. M. (2024) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2024.100193 · Cited by 17
Jawharji, M. T., Alshammari, G. M., Binobead, M. A., Albanyan, N. M., Al‐Harbi, L. N., & Yahya, M. A. (2024) · Nutrients · doi:10.3390/nu16183074 · Cited by 12
“…DM (T1DM) and type 2 DM (T2DM), based on the etiology [1]: while T1DM is mainly attributed to the immune destruction of pancreatic beta cells, T2DM is highly linked to insulin resistance (IR), which is associated with low physical activity, an unhealthy diet, obesity, and metabolic syndrome [1,2].”
BackgroundXu, X., Liu, X., Liu, L., Chen, J., Guan, J., & Luo, D. (2024) · Food & Function · doi:10.1039/d4fo01870b · Cited by 13
Gao, J., Yuan, L., Jiang, H., Li, G., Zhang, Y., Zhou, R., Xian, W., Zou, Y., Du, Q., & Zhou, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1448308 · Cited by 13
Cathelicidin: Insights into Its Impact on Metabolic Syndrome and Chronic Inflammation
Popa, A. D., Gherasim, A., Caba, L., Niță, O., Graur, M., Mihalache, L., & Arhire, L. I. (2024) · Metabolites · doi:10.3390/metabo14120672 · Cited by 11
“This inhibits Ca 2+ mobilization and activates proapoptotic signals in the pancreatic β -cells [68].”
Mukharya, A., Pokale, R., Roy, A. A., Soman, S., Kulkarni, S., Madhusoodanan, G., Manikkath, J., Farhana, S. A., Pandey, A. P., & Mutalik, S. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106590 · Cited by 17
Green, C., Zaman, V., Blumenstock, K., Banik, N. L., & Haque, A. (2025) · Biomedicines · doi:10.3390/biomedicines13010132 · Cited by 13
“The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) states that T2DM is a condition in which the pancreas does not make enough insulin to help glucose reach cells in the body, and this causes the blood glucose or blood sugar level to be extremely high [32,33].”
The Potential of Mesenchymal Stem Cell-Derived Exosomes to Treat Diabetes Mellitus
Kim, J.-E., Lee, J. W., Cha, G. D., & Yoon, J. (2025) · Biomimetics · doi:10.3390/biomimetics10010049 · Cited by 12
Characterizing Circulating microRNA Signatures of Type 2 Diabetes Subtypes
Sulaiman, F., Khyriem, C., Dsouza, S., Abdul, F., Alkhnbashi, O. S., Faraji, H., Farooqi, M. H., Alawadi, F., Hassanein, M., Ahmed, F. S., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020637 · Cited by 14
Guo, Y., Xu, N., Meng, Q., Zhong, M., Yang, M., Xu, F., Zhang, L., Jiang, M., Wu, J., Ma, Z., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119938 · Cited by 13
Baliou, S., Apetroaei, M.-M., Hatzidaki, E., Kuzmin, S. V., Tzatzarakis, M. N., Arsene, A. L., Tsatsakis, A. M., & Ιωάννου, Π. (2025) · Life · doi:10.3390/life15060873 · Cited by 21
Nguyen, N. H., Pham, T. H. T., Nguyen, N. T. T., Bui, V. K. H., & Giau, V. V. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402806 · Cited by 12
“Additionally, symptoms and medical history are considered during the diagnostic process [11].”
Lembo, M., Trimarco, V., Izzo, R., Pacella, D., Jankauskas, S. S., Gallo, P., Piccinocchi, R., Morisco, C., Piccinocchi, G., Bardi, L., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02798-2 · Cited by 13
Trașcă, D.-M., Dop, D., Stoica, G. A., Niculescu, Ș. A., Carmen, N. E., Văruț, R. M., & Singer, C. E. (2025) · Pharmaceuticals · doi:10.3390/ph18071035 · Cited by 12
“This form may range from predominant insulin resistance with a relative insulin deficiency to a predominant insulin secretory defect accompanied by insulin resistance [57] III.”
Shrivastav, K., Nasser, H., Ikeda, T., & Nema, V. (2025) · Viruses · doi:10.3390/v17070990 · Cited by 10
Biosynthesized Silver Nanoparticles and Their Antidiabetic Potential
González-Garibay, A. S., Torres-González, O. R., Sánchez-Hernández, I. M., & Padilla‐Camberos, E. (2025) · Pharmaceuticals · doi:10.3390/ph18091412 · Cited by 18
“On the other hand, sustained hyperglycemia induces the formation of advanced glycation end-products (AGEs), which worsen oxidative stress and non-enzymatic glycation in proteins such as hemoglobin [69].”
InfluentialLi, E., Maunder, A., Liu, J., Pandey, C., Cave, A. E., O’Fee, A., & Ee, C. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-05059-7 · Cited by 19
“T2DM is characterised by insulin resistance in normally insulin-sensitive tissues and pancreatic β-cell dysfunction [2], with the resultant hyperglycaemia leading to serious long-term sequelae such as cardiovascular disease and blindness due to retinopathy [3].”
Chen, M., Huang, J., Gao, D., Li, Y., & Wang, H. (2021) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13621 · Cited by 9
Protective Role of Recombinant Human Thrombomodulin in Diabetes Mellitus
Okano, Y., Takeshita, A., Yasuma, T., Toda, M., Nishihama, K., D’Alessandro, V. F., Inoue, C., D’Alessandro‐Gabazza, C. N., Kobayashi, T., Yano, Y., et al. (2021) · Cells · doi:10.3390/cells10092237 · Cited by 9
“Type 2 DM is associated with lifestyle and genetic factors that cause insulin resistance, impaired biosynthesis and secretion of insulin, and reduced β-cell mass, resulting in a relative insufficiency of insulin activity [8].”
BackgroundKumar, S. U., Kamaraj, B., Varghese, R. P., Preethi, V. A., Bithia, R., & Doss, C. G. P. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.02.005 · Cited by 10
Park, Y. M., Yang, C. M., & Cho, H. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136877 · Cited by 11
“Obesity increases the levels of circulating free fatty acids and decreases glucose uptake in muscles, promoting insulin resistance and, subsequently, diabetes [3].”
BackgroundJangid, R., Jain, S., Sharma, M. K., & Chatterjee, S. (2022) · Vegetos · doi:10.1007/s42535-022-00487-z · Cited by 12
“Type 2 Diabetes Mellitus (T2DM) is the most common type of DM and is caused by the combination of decreased insulin secretion by pancreatic β-cells and lower to no response of insulin-sensitive tissues towards insulin (Galicia-Garcia et al. 2020).”
BackgroundAnsari, P., Hannan, J. M. A., Seidel, V., & Abdel‐Wahab, Y. H. A. (2022) · Metabolites · doi:10.3390/metabo12100995 · Cited by 22
“The rapidly increasing prevalence of type 2 diabetes mellitus (T2DM) is primarily attributable to obesity and physical inactivity, making it the most prevalent form worldwide [5].”
BackgroundKim, K. J., Park, S.-Y., Kim, J. T., Lee, H. J., Jung, S. K., Kim, Y., Lee, C. H., Byun, S., & Kim, J. Y. (2022) · Food Bioscience · doi:10.1016/j.fbio.2022.102180 · Cited by 10
Salauddin, A., Chakma, K., Hasan, M. M., Akter, F., Chowdhury, N. A., Chowdhury, S. R., & Mannan, A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08081-x · Cited by 10
“The pathophysiology of T2DM is triggered by an imbalance of insulin sensitivity caused by β cell dysfunction resulting in the formation of insulin resistance [5].”
BackgroundBortoletto, A. S., & Parchem, R. J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.369095 · Cited by 12
Negahdari, S. (2023) · Journal of Biochemicals and Phytomedicine · doi:10.34172/jbp.2023.3 · Cited by 10
Hisamuddin, A. S.-D. B., Naomi, R., Manan, K. A. B., Bahari, H., Othman, F., Embong, H., Ismail, A., Ahmed, Q. U., Jumidil, S. H., Hussain, M. K., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1175907 · Cited by 12
“During the 12-week follow-up, the body weight of the DNS group remained low compared to the NS group, proving the theory that excessive weight loss is common clinical pathology in diabetic subjects (Galicia-Garcia et al., 2020).”
ResultEndogenous Biological Drivers in Diabetic Lower Limb Wounds Recurrence: Hypothetical Reflections
Berlanga‐Acosta, J., Ojalvo, A. G., Guillén, G. E., & Ayala‐Ávila, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210170 · Cited by 11
“For T2DM, its incidence has progressively escalated, approaching a pandemic condition that accounts for 90% to 95% of the diabetic population [4].”
BackgroundInsights into the role of vitamin D in targeting the culprits of non-alcoholic fatty liver disease
Abdelrahman, B. A., El-Khatib, A. S., & Attia, Y. M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122124 · Cited by 11
Sanneur, K., Leksawasdi, N., Sumonsiri, N., Techapun, C., Taesuwan, S., Nunta, R., & Khemacheewakul, J. (2023) · Foods · doi:10.3390/foods12203738 · Cited by 10
Ni, X., Tong, C., Halengbieke, A., Cao, T., Tang, J., Tao, L., Zheng, D., Han, Y., Li, Q., & Yang, X. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110993 · Cited by 12
Metadata
- Authors
- Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C.
- Affiliations
- Fundación Biofisika Bizkaia, Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Harvard University (US)
- CIC biomaGUNE (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-08-30
- Volume
- 21
- Issue
- 17
- Pages
- 6275
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7503727
- OpenAlex
- W3081655479
- Cited by
- 3,360
- References
- 297
- Citations by year
- 2026: 627 · 2025: 783 · 2024: 812 · 2023: 646 · 2022: 379 · 2021: 100 · 2020: 7
- FWCI
- 64.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Communities in ADDI (University of the Basque Country) (submittedVersion, other-oa)
- Communities in ADDI (Universidad del Pais Vasco) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Hispana (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, pancreatic beta cells, insulin biosynthesis, insulin signaling, glucose homeostasis, gut dysbiosis, metabolic memory, nutrition, physical activity, atherosclerosis, cardiovascular risk
- MeSH terms
- Insulin Secretion, Animals, Blood Glucose, Diabetes Mellitus, Type 2, Homeostasis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.